COVID-19 vaccine: Moderna says preparing for launch; report shows 'strong immune response'
- The COVID-19 vaccine was generally well-tolerated across all age groups and induced rapid and strong immune responses, a study shows
- Dubbed as mRNA-1273, the vaccine has been developed by Moderna in partnership with the US government’s National Institutes of Health